Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 2Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Giant Cell Tumor of Tendon Sheath 3Synovitis, Pigmented Villonodular 2Neoplasm Metastasis 2Melanoma 2Gastrointestinal Stromal Tumors 2Stage I Prostate Adenocarcinoma 1Solid Tumors 1Solid Tumor 1Recurrence 1Pancreatic Neoplasms 1Neoplasms 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1Glioblastoma 1Colorectal Neoplasms 1Breast Neoplasms 1Advanced Solid Tumors 1

Interventions

pexidartinib 2nilotinib 2cabiralizumab 1Tolbutamide 1Midazolam 1Bro protein, Drosophila 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Synovitis, Pigmented Villonodular × pexidartinib × Clear all
NCT02371369 2022-05-11

ENLIVEN

Daiichi Sankyo

Phase 3 Completed
120 enrolled 25 charts 1 FDA

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

NCT03291288 2021-05-14

Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)

Daiichi Sankyo

Phase 1 Completed
32 enrolled 22 charts

Synovitis, Pigmented Villonodular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡